Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

RWJ-51204

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
RWJ-51204
Identifiers
  • 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5] imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide
CAS Number
PubChemCID
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC21H19F2N3O3
Molar mass399.398 g·mol−1
3D model (JSmol)
  • Fc1ccccc1NC(=O)C=3C(=O)CCN4c2c(cc(F)cc2)N(C=34)COCC
  • InChI=1S/C21H19F2N3O3/c1-2-29-12-26-17-11-13(22)7-8-16(17)25-10-9-18(27)19(21(25)26)20(28)24-15-6-4-3-5-14(15)23/h3-8,11H,2,9-10,12H2,1H3,(H,24,28) checkY
  • Key:VQOQDABVGWLROX-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

RWJ-51204 is ananxiolytic drug used in scientific research. It has similar effects tobenzodiazepine drugs, but is structurally distinct and so is classed as anonbenzodiazepine anxiolytic.

RWJ-51204 is a nonselectivepartial agonist atGABAA receptors.[1] It produces primarily anxiolytic effects at low doses, withsedative,ataxia andmuscle relaxant effects only appearing at some 20x the effective anxiolytic dose.[2] It was discovered by researchers at the pharmaceutical companyJohnson & Johnson,[3][4] but its development has been discontinued.

References

[edit]
  1. ^Atack JR (August 2003). "Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site".Current Drug Targets. CNS and Neurological Disorders.2 (4):213–32.doi:10.2174/1568007033482841.PMID 12871032.
  2. ^Dubinsky B, Vaidya AH, Rosenthal DI, Hochman C, Crooke JJ, DeLuca S, DeVine A, Cheo-Isaacs CT, Carter AR, Jordan AD, Reitz AB, Shank RP (November 2002). "5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic".The Journal of Pharmacology and Experimental Therapeutics.303 (2):777–90.doi:10.1124/jpet.102.036954.PMID 12388665.S2CID 23880756.
  3. ^US 5817668, Reitz AB, Jordan AD, Sanfilippo PJ, Vavouyios-Smith A, issued 6 October 1998, assigned to Ortho Pharma Corp 
  4. ^Cohen JH, Maryanoff CA, Stefanik SM, Sorgi KL, Villani FJ (1999). "Process research for the synthesis of RWJ-51204, a novel anxiolytic agent".Organic Process Research & Development.3 (4):260–265.doi:10.1021/op990182l.
5-HT1ARTooltip 5-HT1A receptoragonists
GABAARTooltip GABAA receptorPAMsTooltip positive allosteric modulators
Gabapentinoids
(α2δVDCCblockers)
Antidepressants
Sympatholytics
(Antiadrenergics)
Others
Alcohols
Barbiturates
Benzodiazepines
Carbamates
Flavonoids
Imidazoles
Kava constituents
Monoureides
Neuroactive steroids
Nonbenzodiazepines
Phenols
Piperidinediones
Pyrazolopyridines
Quinazolinones
Volatiles/gases
Others/unsorted


Stub icon

This article about ananxiolytic is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=RWJ-51204&oldid=1248463294"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp